Back to BlackRock, Inc. BlackRock, Inc.

CHRSCHRS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in COHERUS ONCOLOGY INC

BlackRock, Inc. holds 12M shares of CHRS (COHERUS ONCOLOGY INC), worth $16.8M as of 2026-Q2. The position was increased (+15.8% shares). CHRS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$16.8M

Current Shares

12M

Total Value Change

+$1.5M

Total Shares Change

+927,401

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12M
+15.8%
$16.8M0.0%$1.40
33
2026-Q1
Decreased
10.4M
-1.9%
$17.5M0.0%$1.65
0
2025-Q4
Increased
10.6M
+1.0%
$15M0.0%$1.41
28
2025-Q3
Decreased
10.5M
-2.6%
$17.2M0.0%$1.70
0
2025-Q2
Decreased
10.7M
-2.2%
$7.9M0.0%$0.74
0
2025-Q1
Decreased
11M
-0.9%
$8.9M0.0%$0.84
0
2024-Q4
New
11.1M
-
$15.3M0.0%$1.50
39

Other major holders of CHRS: BNP PARIBAS FINANCIAL MARKETS, Temasek Holdings (Private) Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used